#USA #Washington, D.C. #Greenberg Traurig #Gail Javitt #FDA Practice

Greenberg Traurig Expands its Health Care Practice with Gail Javitt

Greenberg Traurig, LLP, a leading global law firm, is making strides in its Health Care and FDA Practice with the recent addition of Gail H. Javitt. Based in Washington, D.C., Javitt joins the firm bringing over three decades of expertise in food and drug law. Her impressive background includes advising a diverse range of clients, from innovative startups to established industry leaders, on a multitude of regulatory, compliance, and transactional matters pertaining to the U.S. Food and Drug Administration (FDA).

Ernest LaMont Greer, Co-President of Greenberg Traurig and Chairman of its Washington, D.C. office, highlighted the significance of Javitt’s appointment, asserting that her expertise enhances the firm's capabilities in addressing complex regulatory challenges. This expansion reflects the firm’s commitment to delivering exceptional service within an increasingly complex and competitive landscape.

Javitt's extensive knowledge encompasses a wide array of regulatory issues, especially those affecting medical device, diagnostic, pharmaceutical, and biological product companies. Her experience doesn’t just end there; she also advises clinical laboratories and genomic interpretation firms on the ever-evolving legal requirements governing laboratory-developed tests. In the corporate environment, she has a proven track record in regulatory due diligence, aiding buyers, sellers, and insurance underwriters in navigating the often-complex terrain of corporate transactions.

As the FDA-regulated industries continue to innovate at a rapid pace, companies are met with a dynamic legal and policy framework. Tricia A. Asaro, Co-Chair of the Health Care & FDA Practice, expressed confidence in Javitt’s abilities to provide valuable insights that will help clients manage risk and capitalize on emerging opportunities. Her presence expands the firm's resources for clients worldwide, particularly as they adapt to new regulatory requirements that influence their operations.

In addition to her consulting work, Javitt is widely recognized for her thought leadership in the health care sector. She has authored various publications and given numerous talks on pressing legal and ethical issues, including FDA regulations related to genetic testing and precision medicine. Her academic affiliations include appointments at prestigious institutions such as Johns Hopkins University, Georgetown University, and the University of Maryland.

Reflecting on the convergence of scientific discovery and regulatory challenges, Javitt noted her commitment to collaborating with innovators striving to bring new health care solutions to market. She aims to leverage Greenberg Traurig’s global platform to deliver comprehensive legal counsel that supports the growth and success of its clients across industries.

Gail Javitt's arrival marks a crucial step in Greenberg Traurig’s ongoing strategic growth in Washington, D.C., following the recent addition of other distinguished attorneys and professionals in multiple fields, including real estate and government affairs. This era of growth signals the firm’s dedication to enhancing its services across all practice areas, particularly as they continue to expand their Health Care and FDA Practice.

In conclusion, Greenberg Traurig, LLP stands out as a leader in providing innovative and strategic legal services globally. With the addition of Gail H. Javitt, clients can expect unparalleled guidance amid the challenges posed by evolving regulations and market dynamics. The firm, recognized for its philanthropic efforts and strong relationships with clients, is committed to ensuring its clients navigate these complexities successfully.